文献速递慢性静脉疾病

髂静脉支架血栓形成的病因分析

Etiology of iliocaval stent thrombosis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2019-12-14

该研究回顾性分析了2012年2月至2016年7月间1381例慢性静脉功能不全患者的2228次髂静脉造影与血管内超声检查,其中18例(0.8%)发生支架完全血栓形成。血栓切除或溶栓后造影显示,支架内再狭窄(11例)和股总静脉流入道病变(6例)是支架血栓最常见的潜在病因,未发现近端病变。

要点

  • 髂静脉支架完全血栓形成率低(0.8%),多无深静脉血栓史。
  • 支架内再狭窄和股总静脉流入道病变是主要病因。
  • 血栓清除后处理潜在病变并抗凝6个月,随访无再血栓。

核心结论

  • 支架内再狭窄和股总静脉流入道病变是髂静脉支架血栓最常见的病因。

研究设计与样本

  • 回顾性分析2012年2月至2016年7月间在门诊手术中心完成的2228次髂静脉造影与血管内超声检查,涉及1381例慢性静脉功能不全且压迫治疗失败的患者。

主要发现

  • 18例(0.8%)发生髂静脉支架完全血栓形成,均接受抽吸血栓切除联合溶栓,均无深静脉血栓史。
  • 血栓清除后造影显示支架内再狭窄11例,股总静脉病变6例,髂外静脉病变2例,无近端病变。
  • 支架血栓与年龄、性别、侧别、位置、症状、支架长度或直径均无相关性。

关键数值与推荐

  • 所有手术均使用Wallstent支架,直径8-24 mm,长度40-90 mm。
  • 术后氯吡格雷使用3个月或继续原有抗凝治疗。
  • 血栓切除术后抗凝6个月,随访无再血栓形成。

临床怎么用

  • 髂静脉支架术后血栓形成时,应重点评估支架内再狭窄和股总静脉流入道病变。
  • 血栓清除后应对潜在病变进行支架置入,并给予6个月抗凝。

局限性

  • 回顾性单中心研究,样本量有限,血栓事件仅18例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although correction of iliac vein stenosis is safe and efficacious, one of its major complications is iliac vein stent thrombosis. In an attempt to examine the cause of iliac vein stent thrombosis, we reviewed the location of underlying lesions encountered after thrombectomy or thrombolysis of iliac vein stents. METHODS: A retrospective analysis was performed of all iliac vein venograms with intravascular ultrasound examinations at our office-based surgical center from February 2012 to July 2016. Patients included in the study had chronic venous insufficiency and failed compression therapy. All procedures were performed with local anesthesia and conscious sedation. Wallstents were used in all procedures for nonthrombotic iliac vein stenosis, ranging from 8 to 24 mm in diameter and 40 to 90 mm in length. Patients were followed with transcutaneous duplex every 3 months for the first year and every 6 to 12 months thereafter. Patients were placed on clopidogrel for 3 months or continued on their preexisting anticoagulants. RESULTS: From February 2012 to July 2016, we performed 2228 iliac vein venograms with intravascular ultrasound examination in 1381 patients. The mean age of the patient population was 65 ±14 years (range, 21-99 years), among which 876 were female. A total of 1037 procedures were performed in the left lower extremity. Of these, 240 venograms were diagnostic. Presenting symptoms based on CEAP classification included C2 (n = 21), C3 (n = 633), C4 (n = 1065), C5 (n = 269), and C6 (n = 241). Complete thrombosis of the iliac vein stent was noted in 18 patients (0.8%) who thereafter underwent suction thrombectomy with thrombolysis. None of these patients had a prior history of deep vein thrombosis. In-stent restenosis was noted in 11 patients. Proximal lesions were found in no patients. An external iliac vein lesion was found distal to the common iliac vein stent in two patients. Common femoral vein lesions were found in six patients. These encountered lesions were then stented. All patients who underwent thrombectomy were placed on anticoagulation for 6 months. No patient were noted to suffer rethrombosis upon follow-up. No correlation with stent thrombosis was encountered for age, gender, laterality, location, presenting symptoms, or length or diameter of the stent. CONCLUSIONS: Based on our experience, in-stent restenosis followed by inflow lesions in the common femoral vein are the most common causes of stent thrombosis. These data suggest a need for future research to target these areas.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Aurshina A, Ascher E, Haggerty J, et al. Etiology of iliocaval stent thrombosis. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31843484. doi:10.1016/j.jvsv.2019.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。